BETTERLIFE PHARMA INC. Current Accrued Expenses And Other Current Liabilities
BETTERLIFE PHARMA INC. (BETRF) had Current Accrued Expenses And Other Current Liabilities of CAD 4.50 million as of 2025-01-31, per its 20-F filed 2025-06-02.
Financial Statements › Notes
ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities · last filed 2025-06-02
- 2025-01-31: Current Accrued Expenses And Other Current Liabilities 4.50M CAD.
- 2024-01-31: Current Accrued Expenses And Other Current Liabilities 4.98M CAD.
- 2023-01-31: Current Accrued Expenses And Other Current Liabilities 5.44M CAD.
- 2022-01-31: Current Accrued Expenses And Other Current Liabilities 3.34M CAD.
| Period end | Current Accrued Expenses And Other Current Liabilities |
|---|---|
| 2025-01-31 | 4.50M CAD 20-F · filed 2025-06-02 |
| 2024-01-31 | 4.98M CAD 20-F · filed 2025-06-02 |
| 2023-01-31 | 5.44M CAD 20-F · filed 2024-05-30 |
| 2022-01-31 | 3.34M CAD 20-F/A · filed 2023-06-06 |
| 2021-01-31 | 4.50M CAD 20-F · filed 2022-06-06 |
| 2020-01-31 | 890.14K CAD 20-F/A · filed 2021-06-23 |
| 2019-01-31 | 637.30K CAD 20-F/A · filed 2020-06-05 |
| 2018-01-31 | 267.89K CAD 20-F/A · filed 2020-06-05 |